Wolverine Trading’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,600
Closed -$230K 4599
2023
Q3
$230K Sell
2,600
-4,000
-61% -$393K ﹤0.01% 3600
2023
Q2
$641K Buy
6,600
+3,100
+89% +$308K ﹤0.01% 2379
2023
Q1
$326K Buy
3,500
+600
+21% +$60.2K ﹤0.01% 2936
2022
Q4
$333K Sell
2,900
-1,500
-34% -$162K ﹤0.01% 2676
2022
Q3
$386K Buy
4,400
+1,800
+69% +$186K ﹤0.01% 2892
2022
Q2
$271K Buy
+2,600
New +$293K ﹤0.01% 3174
2022
Q1
Sell
-3,400
Closed -$499K 5574
2021
Q4
$499K Buy
+3,400
New +$413K ﹤0.01% 3456
2021
Q2
Sell
-2,800
Closed -$232K 6118
2021
Q1
$232K Buy
+2,800
New +$226K ﹤0.01% 4840
2019
Q4
Sell
-7,000
Closed -$345K 4739
2019
Q3
$345K Sell
7,000
-1,400
-17% -$74.3K ﹤0.01% 3016
2019
Q2
$471K Buy
+8,400
New +$433K ﹤0.01% 2776
2018
Q3
Sell
-22,300
Closed -$960K 5052
2018
Q2
$960K Hold
22,300
﹤0.01% 2308
2018
Q1
$960K Buy
+22,300
New +$1.12M ﹤0.01% 2308

Other funds holding CURE

Wolverine Trading's CURE Position: Q1 2022 in Review

Wolverine Trading sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q1 2022, closing a stake of 1,724 shares — an estimated $253K sold.

Wolverine Trading first reported a position in CURE in Q1 2018 and held it in 4 quarters. The position peaked at $273K in Q3 2021. 22 funds tracked by Wall St. Rank hold CURE as of Q1 2022.

  • Wolverine Trading reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 1,724 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2022, an estimated $253K.
  • Wolverine Trading first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2018 and held it in 4 quarters.
  • Wolverine Trading's Direxion Daily Healthcare Bull 3X ETF position peaked at $273K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.